Chapter 2 - The Audit and the Discovery

The shockwave of the divorce petition hit Marcus like a physical blow. By that evening, my phone—though unlisted—began receiving frantic, blocked-number voicemails, followed by a barrage of angry emails sent to my professional account demanding an explanation.
“Clara, have you lost your mind?” one email read. “Serving me papers at a public hospital gala? Do you have any idea how humiliating this is for my career? Call me immediately.”
I didn't reply. I forwarded every single communication directly to Sarah’s legal file, noting each message as potential evidence of harassment.
Three days after the service, Sarah called me into her office for a strategic briefing. She closed the heavy oak door, sat down behind her desk, and slid a thick stack of printed financial reports across to me.
“Clara, when you initially brought me the hospital logs, I assumed Marcus was just an emotionally detached, arrogant surgeon who prioritized his career over his marriage,” Sarah said, her expression grim and professional. “So, as a matter of standard due diligence for high-net-worth dissolutions, my team ran a routine forensic sweep of your joint tax returns and corporate disclosures.”
She pointed a polished fingernail at a series of highlighted figures on the spreadsheet. “Marcus isn't just an elite surgeon earning a standard hospital salary. Over the past three years, he has received nearly four million dollars in undisclosed consulting fees, research grants, and advisory retainers from a medical device manufacturer called Apex BioTech.”
I stared at the numbers, my heart skipping a beat. “Apex BioTech? Marcus mentioned them occasionally at dinner. He said they were developing advanced heart valve replacements.”
“They are,” Sarah replied smoothly. “And Marcus happens to be the lead clinical trial evaluator for their flagship artificial valve. But here is where it becomes illegal. Under federal healthcare compliance laws and Metropolitan General’s strict conflict-of-interest bylaws, any physician evaluating medical hardware in a public hospital clinical trial is legally prohibited from accepting direct financial compensation or equity from the manufacturing company.”
She flipped to a second document—a certified corporate registry filing. “The millions from Apex BioTech weren't paid directly to Marcus. They were funneled through a shell company registered in Delaware under a disguised corporate title: Vanguard Medical Solutions LLC. And the primary managing partner listed on the incorporation paperwork isn't Marcus.”
I held my breath. “Who is it?”
“Dr. Richard Vance,” Sarah said, naming the chief of surgery at Metropolitan General—and Marcus’s lifelong mentor. “Your husband and his chief of surgery have been running a systematic kickback ring, fast-tracking unapproved medical devices into hospital surgeries in exchange for multi-million-dollar payouts, while falsifying patient safety logs to cover their tracks.”
The pieces of the puzzle clicked violently into place in my mind. For months, Marcus had been spending late nights at the hospital, guarding his private laptop, and acting unusually defensive whenever I asked about his administrative duties. It wasn't just an affair or professional ambition keeping him away from my hospital bed. He had been terrified that an independent investigation—or worse, a curious healthcare quality auditor like his own wife—might stumble across his illegal financial empire.
That was why he hadn't visited me. It wasn't because he was too busy saving lives. It was because every moment spent near my hospital room felt like a security risk to his criminal enterprise.
May you like
“What do we do?” I asked, my voice steady, cold, and razor-sharp.
Sarah smiled—a fierce, predatory grin that meant business. “We don't just file for a standard divorce anymore, Clara. We hand this entire corruption scandal directly to the federal inspector general, the state medical board, and the investigative journalism desk at the Chicago Tribune. We are going to strip him of everything.”